InsiderTradr

Suraksha Diagnostic Limited (SURAKSHA.BO)

BSE · INR · Healthcare · Diagnostics & Research

₹310.35 (-0.51%) as of

Key statistics

Market cap
16.16B
P/E (TTM)
45.11
Forward P/E
31.67
EPS (TTM)
6.88
Dividend yield
0.16%
52-week range
224.10 – 359.00
Revenue (TTM)
3.25B
Profit margin
11.00%
Analyst target
₹350.00
Volume
886.00

About Suraksha Diagnostic Limited

Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India.

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
Kolkata, India
Employees
1,600

surakshanet.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks